Inventor
SHEPPECK JAMES
US11 patents
⚠️ This page may combine multiple inventors who share the name “SHEPPECK JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
10 patentsUS7041693B2May 9, 2006
Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
BRISTOL MYERS SQUIBB CO26 citations90
US7211671B2May 1, 2007
Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
BRISTOL MYERS SQUIBB CO15 citations83
US7253283B2Aug 7, 2007
Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO6 citations73
US7074810B2Jul 11, 2006
Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
BRISTOL MYERS SQUIBB CO6 citations60
US7544808B2Jun 9, 2009
Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO0 citations51
US7625921B2Dec 1, 2009
Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO0 citations41
US7569689B2Aug 4, 2009
Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO0 citations41
US7132432B2Nov 7, 2006
Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
BRISTOL MYERS SQUIBB CO0 citations41
US7605264B2Oct 20, 2009
Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO0 citations40
US7361654B2Apr 22, 2008
Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
BRISTOL MYERS SQUIBB CO0 citations39